BCL2 and pancreatic neoplasm: Triptolide and its analogs have been shown to inhibit NF-κB signaling, which in pancreatic cancer cells results in elevated oxidative stress, reduced Bcl-2 expression, and activation of mitochondrial apoptosis pathways (100).